case_images: PMC10363977_01
case_images: (A-C) Panel of radiological imaging concerning basal condition (June 2020) and presence of lung metastases. (D-F) Panel of radiological imaging concerning response to treatment (September 2020).
case_images: fonc-13-1145986-g001.jpg
case_images: PMC10363977_01_fonc-13-1145986-g001.jpg
case_images: f1
case_images: Three months later (September 2020), a CT scan evaluation showed partial response with 80% reduction of lung metastases ( Figures 1A-F ) and appearance of some cavitations ( Figures 2A, B ).
case_images: (A, B) Radiological evidence of "air-filled" cavitation.
case_images: fonc-13-1145986-g002.jpg
case_images: PMC10363977_01_fonc-13-1145986-g002.jpg
case_images: f2
case_images: Three months later (September 2020), a CT scan evaluation showed partial response with 80% reduction of lung metastases ( Figures 1A-F ) and appearance of some cavitations ( Figures 2A, B ).
case_images: Clinical trend of biochemical markers (CA 125, CA 15.3, and HE4) and hematological inflammatory marker (NLR) according to response to treatment and "stop and go" strategy.
case_images: fonc-13-1145986-g003.jpg
case_images: PMC10363977_01_fonc-13-1145986-g003.jpg
case_images: f3
case_images: Treatment and history timeline.
case_images: fonc-13-1145986-g004.jpg
case_images: PMC10363977_01_fonc-13-1145986-g004.jpg
case_images: f4